CT
Chemomab Therapeutics Ltd DRC
🇺🇸XNAS.CMMBUnited StatesHealthcare
$2.63USDup +0.16 (+6.48%)OpenDelayed6:44 PM
FzScore
betaAnalysis is in beta - data may have gaps.
38/ 100
- Poor0-34
- Weak35-49
- Fair50-64
- Strong65-79
- Excellent80-100
Calculated Jun 28, 2026 - Next rebalance Jul 5, 2026 - Coverage 100%
Category radar
How to read
Each axis is a scored category from 0 to 100; a larger footprint is better and an unscored axis collapses to the centre.